{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T19:43:08Z","timestamp":1775072588643,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.beem.2022.101636","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T20:56:28Z","timestamp":1646254588000},"page":"101636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Recurrence risk of autoimmune thyroid and endocrine diseases"],"prefix":"10.1016","volume":"37","author":[{"given":"Lara","family":"Frommer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochem","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Chatzidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Chionos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"L\u00e4ngericht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George J.","family":"Kahaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.beem.2022.101636_bib1","doi-asserted-by":"crossref","first-page":"101344","DOI":"10.1016\/j.beem.2019.101344","article-title":"Autoimmune polyglandular diseases","volume":"33","author":"Kahaly","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"issue":"7","key":"10.1016\/j.beem.2022.101636_bib2","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1210\/jc.2002-021845","article-title":"Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up","volume":"88","author":"Dittmar","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2022.101636_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EJE-09-0044","article-title":"Polyglandular autoimmune syndromes","volume":"161","author":"Kahaly","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2022.101636_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40618-017-0740-9","article-title":"Polyglandular autoimmune syndromes","volume":"41","author":"Kahaly","year":"2018","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"10","key":"10.1016\/j.beem.2022.101636_bib5","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2019-00602","volume":"104","author":"Frommer","year":"2019","journal-title":"Autoimmune Polyendocrinopathy. J Clin Endocrinol Metab."},{"issue":"12","key":"10.1016\/j.beem.2022.101636_bib6","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.autrev.2018.05.013","article-title":"Celiac disease and endocrine autoimmunity - the genetic link","volume":"17","author":"Kahaly","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.beem.2022.101636_bib7","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2022.101636_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000490384","article-title":"European thyroid association guideline for the management of graves' hyperthyroidism","volume":"7","author":"Kahaly","year":"2018","journal-title":"Eur Thyroid J"},{"issue":"3","key":"10.1016\/j.beem.2022.101636_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000438750","article-title":"The 2015 European thyroid association guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism","volume":"4","author":"Biondi","year":"2015","journal-title":"Eur Thyroid J"},{"issue":"12","key":"10.1016\/j.beem.2022.101636_bib10","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1210\/clinem\/dgaa646","article-title":"Management of graves thyroidal and extrathyroidal disease: an update","volume":"105","author":"Kahaly","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2022.101636_bib11","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1210\/jc.2013-4026","article-title":"Clinical relevance of thyroid-stimulating autoantibodies in pediatric graves' disease-a multicenter study","volume":"99","author":"Diana","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.beem.2022.101636_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000508790","article-title":"A\u00a0novel long-term graves' disease animal model confirmed by functional thyrotropin receptor antibodies","volume":"9","author":"Diana","year":"2020","journal-title":"Eur Thyroid J"},{"issue":"8","key":"10.1016\/j.beem.2022.101636_bib13","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1210\/clinem\/dgaa288","article-title":"Chromogranin serves as novel biomarker of endocrine and gastric autoimmunity","volume":"105","author":"Ebert","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2022.101636_bib14","doi-asserted-by":"crossref","first-page":"e1307","DOI":"10.1210\/clinem\/dgz021","article-title":"Type I diabetes is the main cost driver in autoimmune polyendocrinopathy","volume":"105","author":"Radermacher","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2022.101636_bib15","doi-asserted-by":"crossref","first-page":"618213","DOI":"10.3389\/fendo.2021.618213","article-title":"Type 1 diabetes and autoimmune thyroid disease-the genetic link","volume":"12","author":"Frommer","year":"2021","journal-title":"Front Endocrinol"},{"issue":"11","key":"10.1016\/j.beem.2022.101636_bib16","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s40618-021-01575-8","article-title":"A\u00a0rapid point-of-care assay accurately measures vitamin D","volume":"44","author":"Albrecht","year":"2021","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"7","key":"10.1016\/j.beem.2022.101636_bib17","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.autrev.2016.02.017","article-title":"Type 1 diabetes associated autoimmunity","volume":"15","author":"Kahaly","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.beem.2022.101636_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/cei.12395","article-title":"Thyroid-associated orbitopathy is linked to gastrointestinal autoimmunity","volume":"178","author":"Ponto","year":"2014","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"10.1016\/j.beem.2022.101636_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/nu10070814","article-title":"Celiac disease and glandular autoimmunity","volume":"10","author":"Kahaly","year":"2018","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.beem.2022.101636_bib20","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1210\/jc.2016-1220","article-title":"Thyroid stimulating antibodies are highly prevalent in hashimoto's thyroiditis and associated orbitopathy","volume":"101","author":"Kahaly","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2022.101636_bib21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/cei.12980","article-title":"Prevalence and clinical relevance of thyroid stimulating hormone receptor-blocking antibodies in autoimmune thyroid disease","volume":"189","author":"Diana","year":"2017","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.beem.2022.101636_bib22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/08916934.2018.1431776","article-title":"Functional TSH receptor antibodies in children with autoimmune thyroid diseases","volume":"51","author":"Stozek","year":"2018","journal-title":"Autoimmunity"},{"issue":"1","key":"10.1016\/j.beem.2022.101636_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","article-title":"Graves' disease","volume":"6","author":"Davies","year":"2020","journal-title":"Nat Rev Dis Prim"},{"issue":"2","key":"10.1016\/j.beem.2022.101636_bib24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41574-019-0305-4","article-title":"New insights into the pathogenesis and nonsurgical management of Graves orbitopathy","volume":"16","author":"Taylor","year":"2020","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2022.101636_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4158\/EP-2019-0363","article-title":"Tsh receptor antibodies: relevance & utility","volume":"26","author":"Kahaly","year":"2020","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.beem.2022.101636_bib26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1056\/NEJMc1614624","article-title":"Graves' disease","volume":"376","author":"Kahaly","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.beem.2022.101636_bib27","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1210\/jc.2018-00509","article-title":"Stimulatory TSH-receptor antibodies and oxidative stress in graves disease","volume":"103","author":"Diana","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2022.101636_bib28","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1210\/jc.2018-02705","article-title":"High titers of thyrotropin receptor antibodies are associated with orbitopathy in patients with graves disease","volume":"104","author":"Kahaly","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2022.101636_bib29","doi-asserted-by":"crossref","first-page":"629925","DOI":"10.3389\/fendo.2020.629925","article-title":"Stimulatory thyrotropin receptor antibodies are a biomarker for graves' orbitopathy","volume":"11","author":"George","year":"2020","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2022.101636_bib30","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz292","article-title":"Prospective trial of functional thyrotropin receptor antibodies in graves disease","volume":"105","author":"Kahaly","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.beem.2022.101636_bib31","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4239\/wjd.v11.i11.527","article-title":"Type 1 diabetes and associated autoimmune diseases","volume":"11","author":"Frommer","year":"2020","journal-title":"World J Diabetes"},{"issue":"1","key":"10.1016\/j.beem.2022.101636_bib32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4239\/wjd.v6.i1.67","article-title":"Type 1 diabetes and polyglandular autoimmune syndrome: a review","volume":"6","author":"Hansen","year":"2015","journal-title":"World J Diabetes"},{"issue":"2","key":"10.1016\/j.beem.2022.101636_bib33","first-page":"5","article-title":"Morbus Addison und pluriglandul\u00e4re Syndrome","volume":"6","author":"Hansen","year":"2013","journal-title":"Austrian Journal of Clinical Endocrinology and Metabolism"},{"issue":"12 P 2","key":"10.1016\/j.beem.2022.101636_bib34","doi-asserted-by":"crossref","first-page":"e663","DOI":"10.1016\/j.lpm.2012.09.011","article-title":"Polyglandular autoimmune syndrome type II","volume":"41","author":"Kahaly","year":"2012","journal-title":"Presse Med"},{"issue":"1","key":"10.1016\/j.beem.2022.101636_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/cen.13482","article-title":"Autoantibodies against the calcium-sensing receptor and cytokines in autoimmune polyglandular syndromes types 2, 3 and 4","volume":"88","author":"Kemp","year":"2018","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2022.101636_bib36","first-page":"222","article-title":"Linkage strategies for genetically complex traits. I. Multilocus models","volume":"46","author":"Risch","year":"1990","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.beem.2022.101636_bib37","first-page":"229","article-title":"Linkage strategies for genetically complex traits. II. The power of affected relative pairs","volume":"46","author":"Risch","year":"1990","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.beem.2022.101636_bib38","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0092-8674(00)81110-1","article-title":"Genetic analysis of autoimmune disease","volume":"85","author":"Vyse","year":"1996","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.beem.2022.101636_bib39","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): national health and nutrition examination survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2022.101636_bib40","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1210\/jc.2008-2291","article-title":"Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review","volume":"94","author":"Golden","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2022.101636_bib41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/clin.1997.4412","article-title":"Epidemiology and estimated population burden of selected autoimmune diseases in the United States","volume":"84","author":"Jacobson","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"issue":"3","key":"10.1016\/j.beem.2022.101636_bib42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1568-9972(03)00006-5","article-title":"The epidemiology of autoimmune diseases","volume":"2","author":"Cooper","year":"2003","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.beem.2022.101636_bib43","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1210\/jc.2018-01974","article-title":"Sex alters the MHC class I HLA-A association with polyglandular autoimmunity","volume":"104","author":"Flesch","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2022.101636_bib44","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1210\/clinem\/dgz164","article-title":"Amino acid polymorphisms in hla class II differentiate between thyroid and polyglandular autoimmunity","volume":"105","author":"Frommer","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.beem.2022.101636_bib45","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaut.2007.11.010","article-title":"The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology","volume":"30","author":"Jacobson","year":"2008","journal-title":"J\u00a0Autoimmun"},{"issue":"1","key":"10.1016\/j.beem.2022.101636_bib46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/EJE-08-0082","article-title":"Early onset of polyglandular failure is associated with HLA-DRB1\u221703","volume":"159","author":"Dittmar","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2022.101636_bib47","doi-asserted-by":"crossref","first-page":"E177","DOI":"10.1210\/jc.2013-2852","article-title":"HLA class II haplotypes differentiate between the adult autoimmune polyglandular syndrome types II and III","volume":"99","author":"Flesch","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2022.101636_bib48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/thy.2008.0301","article-title":"The protein tyrosine phosphatase non-receptor type 22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes","volume":"19","author":"Dultz","year":"2009","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.beem.2022.101636_bib49","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1055\/s-0029-1214414","article-title":"CTLA-4 CT60 polymorphism in thyroid and polyglandular autoimmunity","volume":"41","author":"Dultz","year":"2009","journal-title":"Horm Metab Res"},{"issue":"5","key":"10.1016\/j.beem.2022.101636_bib50","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1210\/jc.2017-02577","article-title":"PTPN22 and CTLA-4 polymorphisms are associated with polyglandular autoimmunity","volume":"103","author":"Houcken","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2022.101636_bib51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/thy.2005.15.239","article-title":"Immunoregulatory and susceptibility genes in thyroid and polyglandular autoimmunity","volume":"15","author":"Dittmar","year":"2005","journal-title":"Thyroid"},{"issue":"8","key":"10.1016\/j.beem.2022.101636_bib52","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1210\/jc.2004-2236","article-title":"Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes","volume":"90","author":"Golden","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2022.101636_bib53","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00063-009-1034-6","article-title":"[Genetics of thyroid autoimmunity - update and clinical relevance]","volume":"104","author":"Dultz","year":"2009","journal-title":"Med Klin"},{"issue":"7","key":"10.1016\/j.beem.2022.101636_bib54","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1089\/thy.2010.1639","article-title":"Genetics of the autoimmune polyglandular syndrome type 3 variant","volume":"20","author":"Dittmar","year":"2010","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.beem.2022.101636_bib55","first-page":"107","article-title":"Infection, thyroid disease, and autoimmunity","volume":"14","author":"Tomer","year":"1993","journal-title":"Endocr Rev"},{"issue":"6416","key":"10.1016\/j.beem.2022.101636_bib56","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/bmj.288.6416.518","article-title":"Methimazole and generation of oxygen radicals by monocytes: potential role in immunosuppression","volume":"288","author":"Weetman","year":"1984","journal-title":"Br Med J"},{"key":"10.1016\/j.beem.2022.101636_bib57","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fendo.2017.00050","article-title":"Environmental issues in thyroid diseases","volume":"8","author":"Ferrari","year":"2017","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2022.101636_bib58","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0031-1271619","article-title":"Increased familial clustering of autoimmune thyroid diseases","volume":"43","author":"Dittmar","year":"2011","journal-title":"Horm Metab Res"},{"issue":"4","key":"10.1016\/j.beem.2022.101636_bib59","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.2337\/diabetes.52.4.1052","article-title":"Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study","volume":"52","author":"Hyttinen","year":"2003","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.beem.2022.101636_bib60","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1530\/eje.1.02060","article-title":"The relative importance of genetic and environmental effects for the early stages of thyroid autoimmunity: a study of healthy Danish twins","volume":"154","author":"Hansen","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2022.101636_bib61","doi-asserted-by":"crossref","first-page":"J307","DOI":"10.1016\/j.jaut.2009.11.019","article-title":"The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution","volume":"34","author":"Hemminki","year":"2010","journal-title":"J\u00a0Autoimmun"},{"issue":"3","key":"10.1016\/j.beem.2022.101636_bib62","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s12020-017-1441-z","article-title":"Heritability of Addison's disease and prevalence of associated autoimmunity in a cohort of 112,100 Swedish twins","volume":"58","author":"Skov","year":"2017","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.beem.2022.101636_bib63","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1530\/EJE-20-0049","article-title":"Co-aggregation and heritability of organ-specific autoimmunity: a population-based twin study","volume":"182","author":"Skov","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.beem.2022.101636_bib64","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1089\/thy.2020.0213","article-title":"Familial risk of hashimoto's thyroiditis among first-degree relatives: a population-based study in Korea","volume":"31","author":"Kim","year":"2021","journal-title":"Thyroid"},{"issue":"8","key":"10.1016\/j.beem.2022.101636_bib65","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1089\/105072503768499653","article-title":"Sibling recurrence risk in autoimmune thyroid disease","volume":"13","author":"Villanueva","year":"2003","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.beem.2022.101636_bib66","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/cen.13323","article-title":"Hashimoto's thyroiditis: relative recurrence risk ratio and implications for screening of first-degree relatives","volume":"87","author":"Bothra","year":"2017","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2022.101636_bib67","doi-asserted-by":"crossref","first-page":"100058","DOI":"10.1016\/j.jtauto.2020.100058","article-title":"Familial risks between Graves disease and Hashimoto thyroiditis and other autoimmune diseases in the population of Sweden","volume":"3","author":"Thomsen","year":"2020","journal-title":"J\u00a0Transl Autoimmun"},{"issue":"3","key":"10.1016\/j.beem.2022.101636_bib68","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/genetics\/144.3.1215","article-title":"The essence of single ascertainment","volume":"144","author":"Hodge","year":"1996","journal-title":"Genetics"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X22000239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X22000239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:58:48Z","timestamp":1761497928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X22000239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1521690X22000239"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2022.101636","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrence risk of autoimmune thyroid and endocrine diseases","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2022.101636","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101636"}}